WORLDWIDE, 26,000 PEOPLE DIE FROM CANCER EACH DAY
By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million.
Earlier diagnosis of cancer results in significantly higher survival rates compared to late-stage diagnosis, increasing the availability of treatment options and improving chances of recovery and a better quality of life.


DXCOVER BRAIN CANCER
With the Dxcover Brain Cancer Liquid Biopsy, doctors will finally have a fast, inexpensive and easy way to accurately test for brain cancer
90%
OF PATIENTS SURVIVE WHEN CANCER IS FOUND EARLY. EARLY DIAGNOSIS BEATS CANCER.
Reference - CRUK Statistics impact of early diagnosis
THE DXCOVER LIQUID BIOPSY IS A BLOOD TEST FOR EARLY DETECTION OF CANCER.
The Dxcover Platform and patented Drop Dry Detect method enables rapid development of a range of tests.
Our Dxcover Cancer project is developing liquid biopsies for the most common cancers.
Our Dxcover Brain Cancer liquid biopsy has successfully completed two clinical studies.